Tyrosine Nitration on p65
A Novel Mechanism to Rapidly Inactivate Nuclear Factor-
B*
Sung Wook Park,
M. D.Mostaqul Huq,
Xinli Hu and
Li-Na Wei
From the Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
 |
ABSTRACT
|
---|
NO is an important factor that induces post-translational modifications of proteins by cellular reduction and oxidation mechanism: cysteinyl-nitrosylation or Tyr nitration. Nuclear factor (NF)-
B activity can be rapidly suppressed by sodium nitroprusside, a NO donor. This effect was effectively reversed by peroxynitrite scavenger deferoxamine, suggesting a Tyr nitration-mediated mechanism. Western blot with nitrotyrosine-specific antibody demonstrated that the p65 subunit of NF-
B was predominantly nitrated on Tyr residues. Tyr nitration of p65 induced its dissociation from p50, its association with I
B
, and subsequent sequestration of p65 in the cytoplasm by I
B
-mediated export. Liquid chromatography-coupled nanoelectrospray mass spectrometry revealed specific nitration on Tyr-66 and Tyr-152 residues of p65. Mutation studies confirmed that both Tyr-66 and Tyr-152 residues were important for the direct effects of NO on p65, which resulted in more p65 export and inactivation of NF-
B activity. This study identified a novel and efficient pathway where NO rapidly inactivated NF-
B activity by inducing Tyr nitration on p65.
NF-
B1 is an inducible transcription factor that regulates the expression of a wide variety of genes. It is a key regulatory factor for various cellular events, including cell survival, cell proliferation, angiogenesis, and metastasis of cancers (14). NF-
B generally exists as homo- or heterodimers of five family members including p50/p105 (NF-
B1), p52/p100 (NF-
B2), c-Rel, RelB, and p65 (RelA).
In most cells, NF-
B is predominantly cytoplasmic and silent because of its association with an inhibitory protein of the I
B family, I
B
, -ß, -
, or Bcl-3. The p50 or p52 homodimer binds to the
B DNA element to repress target gene expression by recruiting nuclear receptor corepressors and histone deacetylases to the target gene promoter (58). Upon stimulation by proinflammatory cytokines, the bacterial cell surface antigen lipopolysaccharide, viral infection, phorbol esters, or radiation, I
B
is phosphorylated by I
B kinase, ubiquitinated, and degraded by a 26 S proteosome protease complex. The dissociated NF-
B p65/p50 heterodimer is then translocated into nuclei to activate target gene expression (9). Translocation into nuclei is considered to be a general activating mechanism for NF-
B. Recently post-translational modifications of p65 have been reported, including phosphorylation and acetylation (7, 1015). These post-translational modifications affect the association of p65 with transcriptional coactivators, such as CBP/p300, or the inhibitory molecules such as I
B
or histone deacetylase 3. Numerous studies have examined the mechanisms underlying NF-
B activation. However, it is less clear whether and how NF-
B can be rapidly and efficiently inactivated by other post-translational modifications.
NF-
B activity is regulated by various factors, including NO. NO is a well known signaling molecule involved in pathophysiological processes such as inflammation, apoptosis, regulation of enzyme activity, and gene expression. NO triggers the cGMP second messenger system, as originally identified in vascular smooth muscle (16), that activates the cGMP-dependent protein kinase. In addition, NO generated by inducible NO synthase or administered exogenously can directly modify target proteins through S-nitrosylation of cysteine residues or nitration of Tyr residues (17, 18). Tyr nitration is caused by peroxynitrite generated from NO and superoxide and is implicated in apoptosis and degenerative diseases. NO can exert anti-inflammatory effects through inhibiting NF-
B activity. Two mechanisms are known to mediate NO suppression of NF-
B activity: one is through S-nitrosylation of the p50 subunit, which results in reduced DNA binding activity (19, 20), and the second is by S-nitrosylation of I
B kinase ß to reduce I
B
phosphorylation (21, 22). Both repressive mechanisms would probably be less efficient once NF-
B has been activated. However, in most cancer cells NF-
B is constitutively active and associated with DNA, and hence, the suppressive effect of NO by S-nitrosylation of the p50 subunit or the I
B kinase ß protein would seem to be inefficient. In our previous studies (23), we found NO rapidly and efficiently suppressed c-myc by inactivating NF-
B in P19 carcinoma cells where NF-
B was constitutively active and peroxynitrite scavenger restored c-myc expression. Similarly NO impaired DNA binding of the NF-
B p65/p50 heterodimer activated by tumor necrosis factor (TNF)-
in HEK293 cells, which was also abolished by peroxynitrite scavenger. The DNA binding of p50 homodimer was not affected. These raised the possibility that NO might inactivate the readily active NF-
B through alternative mechanisms.
The differential effect of NO on the p65/p50 heterodimer (active NF-
B) versus the repressive p50 homodimer suggested that p65 could be the target of the rapid suppressive effect of NO. This observation prompted us to examine an alternative peroxynitrite-triggered mechanism, Tyr nitration on p65. We examined its biological effects, including p65 complex formation, nuclear export of p65, and the subsequent effect on the transcription of endogenous NF-
B target genes. Using liquid chromatography-coupled nanoelectrospray ionization mass/mass spectrometry (LC/MS/MS), we identified two specific Tyr residues of p65 that could be nitrated: Tyr-66 and Tyr-152. Both residues were located in the Rel homology domain of p65. Mutation studies confirmed the role of these two Tyr residues in p65 activity. We now report the studies identifying a novel NO-triggered rapid "off-switch" for NF-
B activity by inducing nitration on two specific Tyr residues of p65.
 |
EXPERIMENTAL PROCEDURES
|
---|
Plasmid Constructions
pEGFP-c1-p65 was constructed by fusing p65 to the C terminus of EGFP (Clontech). The point mutants Y66F and Y152F were constructed from the pairs of point-mutated PCR primers and pEGFP-c1-p65 as a template plasmid by PCR methods using the QuikChange® XL site-directed mutagenesis kit (Stratagene) according to the manufacturers instructions. pcDNA-I
B
was constructed by subcloning I
B
(24) into pcDNA3.1 (Invitrogen).
Cell Culture and Reporter Assay
P19, COS-1, and HEK293 were maintained as described previously (25). SH-SY5Y cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. P19 cells were transiently transfected with a NF-
B-specific reporter construct, p(Igk)4-Luc, and p65 constructs followed by treatment with 0.5 mm sodium nitroprusside (SNP) or 0.1 mm peroxynitrite, and reporter assays were conducted as described previously (23).
Analyses of the mRNA of NF-
B Target Genes
P19 and SH-SY5Y cells were treated with 5 mm DTT, 10 µm deferoxamine (DFO), or 5 µm 1H-(1,2,4)oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ) for 30 min prior to treatment with 0.5 mm SNP for 6 h. HEK293 cells were treated with 10 ng/ml TNF-
for 1 or 2 h followed by addition of SNP. Total RNA was isolated with a TRIzolTM kit (Invitrogen). The endogenous human intracellular adhesion molecule-1 (hICAM-1), cyclin D1, cellular inhibitor of apoptosis protein-1 (cIAP-1), interleukin-8 (IL-8), and mICAM-1 mRNAs were analyzed by reverse transcription-PCR as described previously (23). The sequences of each set of gene-specific primers and the sizes (in parentheses) of expected PCR products were as follows: hICAM-1, 5'-AGCAGCCCCCGGCCCGCG-3' and 5'-GTCACCTTGGCTCTAGGGTG-3' (1012 bp); human cIAP-1, 5'-CGACTTGTCATGTGAACTGTAC-3' and 5'-TTCATCTCCTGGGCTGTCTG-3' (993 bp); human IL-8, 5'-GACTTCCAAGCTGGCCGTGGC-3' and 5'-TGAATTCTCAGCCCTCTTCA-3' (295 bp); human cyclin D1, 5'-AGACCAGCTCCTGTGCTGCG-3' and 5'-CACGTCCCGCACGTCGGTGG-3' (873 bp); mICAM-1, 5'-GCTCCTGGCCCTGGTCACCGTTG-3' and 5'-GAGTTTTATGGCCTCCTCCTGAG-3' (1502 bp); and human actin-ß1 (as an internal control), 5'-CGTCGACAACGGCTCCGGCATG-3' and 5'-GGTGCCAGATTTTCTCCATGTC-3' (236 bp). PCRs were performed at annealing temperatures from 55 to 60 °C with 2735 cycles.
Chromatin Immunoprecipitation (ChIP)
P19 cells were treated with SNP (06 h), and HEK293 cells were treated with TNF-
for 1 or 2 h prior to SNP treatment (090 min). ChIP assays were performed (23) using 2 µg each of anti-p65 (H-286, Santa Cruz Biotechnology, Inc.), anti-p50 (06-886, Upstate Biotechnology), or preimmune serum (Pierce, 31884). Precipitated DNA was amplified by PCR with the following primers specific to the
B flanking sequences of the endogenous mICAM-1 or hICAM-1 promoter: mICAM-1, 5'-TGGTCTCTGACACCACCTCC-3' and 5'-TAGCACTGGGTGCAGACTGA-3'; hICAM-1, 5'-GATTCAAGCTTAGCCTGGCCGG-3' and 5'-GAGTAGCAGAGGAGCTCAGCGTC-3'.
Immunoblotting, Immunoprecipitation, and in Vitro Protein Interaction Assay (His Pull-down)
Nuclear, cytoplasmic, or whole cell extracts were subjected to immunoblotting and/or immunoprecipitation using antibodies as described in each figure legend. I
B
was synthesized using an in vitro transcription and translation kit (Promega, Madison, WI). His-tagged p65 was precipitated with nickel-nitrilotriacetic acid (Ni-NTA)-agarose beads (Qiagen, Valencia, CA) and allowed to interact with 35S-labeled I
B
. Protein complexes were resolved by SDS-PAGE and immunoblot analyses.
In Vitro Nitration and LC-MS/MS Analysis of p65
P19 whole cell extracts or recombinant p65 (GenBankTM accession no. AAA36408) (TransAMTM NF
B p65, Active Motif, Carlsbad, CA) were incubated in a nitration reaction buffer containing 10 mm NaNO2, 9 µm FeCl3, 0.3% H2O2, and 20 mm sodium acetate (pH 5.6) for 24 h at room temperature followed by immunoprecipitation or immunoblotting using anti-NTyr. BSA was included as the in vitro nitration control (26).
Four hundred nanograms of nitrated or unmodified recombinant p65 were digested with trypsin (Promega) using ProPrep (Genomic Solutions, Ann Arbor, MI). After trypsin digestion, 20 µl of the un-nitrated p65 sample were diluted to a final volume of 30 µl in 98:2 water:6-aminocapronitrile, 0.1% trifluoroacetic acid. Nitrated sample was analyzed without dilution. The peptide solution (27.5 µl) in a loading buffer (98:2 water:6-aminocapronitrile and 0.1% formic acid) was aspirated by an LC Packings (Dionex, Sunnyvale, CA) Famos autosampler, and peptides were eluted at 350 nl/min using an LC Packings Ultimate LC system. This LC system is equipped with a C18 nano-precolumn (0.3-mm internal diameter x 5-mm length) and a 12-cm capillary column packed with 5-µm and 200-Å pore size C18 particles (Michrom BioResources, Auburn, CA). Peptides were eluted with a 1.6% solvent B/min linear gradient over 65 min starting with 100% solvent A (where solvent A was 95:5 water:6-aminocapronitrile, 0.1% formic acid and solvent B was 5:95 water:6-aminocapronitrile, 0.1% formic acid). The LC system was on line with an Applied Biosystems (ABI, Foster City, CA) QSTAR Pulsar quadrupole TOF MS system, which was equipped with a Protana nanoelectrospray source. As peptides eluted from the column they were focused into the mass spectrometer where product ion spectra were collected in an information-dependent acquisition mode. Information-dependent acquisition mode settings included continuous cycles of one full TOF MS scan from 4001100 m/z (1.5 s) plus three product ion scans from 502500 m/z (3 s each). Precursor m/z values were selected from a peak list automatically generated by Analyst QS software (ABI) from the TOF MS scan during acquisition, starting with the most intense ion.
Peptide Mass software (Swiss Institute of Bioinformatics; available on line via the ExPASy Molecular Biology Server (www.expasy.org)) was used to generate a theoretical tryptic digest of p65, and 44.9851 Da was added to the mass of Tyr-containing peptides to account for possible nitration. From the LC/MS data, the molecular weights of the detected peptides were calculated using the LC/MS reconstruct feature of Analyst QS. Experimentally measured peptide masses were compared with the theoretical digest, and to confirm the sequence of the peptides and the sites of modification MS/MS spectra were examined using the Sequence Peptide feature of Analyst QS with the following settings: m/z tolerance, 175 ppm; minimum peak height, 3%.
Analysis of p65 Export by Fluorescence Microscopy
HEK293 cells were transfected with pEGFP-c1-p65 plasmid and treated with 10 ng/ml TNF-
for 2 h followed by 0.5 mm SNP or 0.1 mm peroxynitrite for 2 h. Twenty nanomolar leptomycin B (LMB) or 10 µm DFO were added for 2 h or 30 min, respectively, prior to SNP treatment. The cytoplasmic or nuclear green fluorescent protein (GFP)-p65 was scored among at least 200 transfected cells in multiple microscopic fields and photographed using an inverted fluorescence microscope (TE200, Nikon).
 |
RESULTS
|
---|
Peroxynitrite Modulates the Expression of NF-
B Target Genes
The time course of NO effects on NF-
B target genes was examined with reverse transcription-PCR. In P19 and SH-SY5Y cells where NF-
B was constitutively active, SNP suppressed mICAM-1 and cyclin D1 genes (Fig. 1 Aand B, ) within 30120 min. In HEK293 cells where NF-
B was stimulated by TNF-
, SNP also rapidly suppressed the expression of hICAM-1, cIAP-1, and IL-8 genes (Fig. 1C). These results showed that SNP indeed effectively and rapidly inactivated NF-
B. Then to determine whether the rapidly suppressive effect of NO on NF-
B activity could be mediated by peroxynitrite, we examined the expression level of several endogenous NF-
B target genes in the presence of NO. The constitutively active NF-
B target genes mICAM-1 and cyclin D1 were suppressed by SNP, a direct NO donor (Fig. 1, D and E). DFO, a peroxynitrite scavenger, blocked NO-triggered suppression of mICAM-1 gene expression, whereas DTT and ODQ, an S-nitrosylation inhibitor and a guanylate cyclase inhibitor, respectively, had little or slight effect (Fig. 1, D and E). These results suggest that peroxynitrite may be primarily involved in NF-
B inactivation.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 1. Peroxynitrite suppresses NF- B target gene expression. P19, human SH-SY5Y, and HEK293 cells were treated as indicated. Messenger RNA for human and mouse genes were amplified by reverse transcription-PCR. Mouse actin and human actin-ß1 were used as internal controls for each sample. A, mouse ICAM-1 mRNA from P19 cells treated with 0.5 mm SNP for 06 h. B, human cyclin D1 mRNA from SH-SY5Y cells treated with 0.5 mm SNP for 06 h. C, human ICAM-1, cIAP-1, and IL-8 mRNA from HEK293 cells pretreated with TNF- for 1 or 2 h before treatment with 0.5 mm SNP for 02 h. D, mouse ICAM-1 mRNA from P19 cells treated with DTT (5 mm), DFO (10 µm), or ODQ (5 µm) for 30 min prior to treatment with 0.5 mm SNP for 6 h. E, human cyclin D1 mRNA from SH-SY5Y neuroblastoma cells treated with DTT (5 mm), DFO (10 µm), or ODQ (5 µm) for 30 min prior to treatment with 0.5 mm SNP for 6 h. F, human cIAP-1 and ICAM-1 mRNA from HEK293 cells pretreated with 10 ng/ml TNF- for 2h. Samples were then treated with SNP (01.0 mm) for 6 h or with DTT (5 mm), DFO (10 µm), or ODQ (5 µm) for 30 min prior to treatment with 0.5 mm SNP for 6 h. G, P19 cells were transfected with reporter p(Igk)4-Luc and His-p65 followed by treatment with 0.5 mm SNP for 6 h or 0.1 mm peroxynitrite for 2 h. The reporter assay was performed two times independently. CMV indicates a control transfection with cytomegalovirus vector. *, p < 0.05 versus control (Con) of cytomegalovirus vector; **, p < 0.05 versus control of His-p65. RLU, relative luciferase unit.
|
|
We then examined the effects of NO on TNF-
-stimulated NF-
B activity. SNP also suppressed the cIAP-1 and hICAM-1 genes induced by TNF-
-activated NF-
B in HEK293 cells (Fig. 1F). Again the NO-induced suppression of these genes was rescued by DTT and DFO but not by ODQ. Without stimulation by TNF-
, the expression of these genes was hardly affected by SNP (data not shown). Taken together, SNP suppressed all the NF-
B target genes examined through peroxynitrite regardless of the type of NF-
B activation (constitutive or stimulated). To confirm the specific effects of peroxynitrite, P19 cells transfected with His-p65 or a control were treated directly with peroxynitrite, and reporter assays were performed (Fig. 1G). As expected, cotransfection with His-p65 dramatically increased the relative luciferase activity. Both SNP and peroxynitrite effectively suppressed the transcriptional activity of His-p65. These results suggested that NO effectively suppressed NF-
B target genes via peroxynitrite by inactivating both constitutively active and cytokine-activated NF-
B.
Tyr Nitration of p65 Subunit
Because peroxynitrite was known to trigger Tyr nitration, immunoprecipitations were performed in P19 cell extracts treated with SNP to determine the nitrated subunit of the endogenous NF-
B (Fig. 2A). The level of Tyr nitration (
-NTyr) was abundant on p65 (upper panel, lane 2) and much less abundant on p50 (lower panel, lane 2). As predicted, Tyr nitration was completely blocked by DFO (lane 3). Anti-p65 and anti-p50 antibodies confirmed a similar level of protein input. Tyr nitration on p65 was further demonstrated using Ni-NTA-agarose bead precipitates of overexpressed produced His-p65 from COS-1 cells exposed to SNP (Fig. 2B). The precipitates were analyzed with anti-p65 (lanes 13) and anti-NTyr (lanes 4 and 5). Nitrated Tyr was detected on p65 from NO-exposed cells (lane 5) but not from unexposed cells (lane 4). These results confirmed that Tyr nitration triggered by peroxynitrite occurred primarily on the p65 subunit of the NF-
B heterodimer.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2. Tyrosine nitration of the p65 subunit of NF- B. A, P19 cells were pretreated with DFO for 30 min prior to SNP treatment for 6 h. Immune complexes were precipitated with antibodies against p65 (upper panel) or p50 (lower panel) and detected on immunoblots with anti-NTyr antibody. B, whole cell extracts (WCE) of COS-1 cells transfected with His-p65 and treated with SNP for 6 h were precipitated with nickel beads. The precipitates were immunoblotted with anti-p65 (lanes 2 and 3) or anti-NTyr antibodies (lanes 4 and 5). Con, control.
|
|
Tyr Nitration of p65 Inactivates NF-
B
The suppressive effect of peroxynitrite on NF-
B and peroxynitrite-induced Tyr nitration of p65 suggested that Tyr nitration of p65 might act as a molecular switch to inactivate NF-
B. To determine whether rapid inactivation of NF-
B by SNP was correlated with changes of NF-
B binding to its target DNA, ChIP assays were conducted in the P19 cell model (Fig. 3A). Clearly p65 left the
B element of the endogenous mICAM-1 promoter upon SNP treatment, whereas p50 was further recruited to the same site. To address this in the TNF-
-stimulated situation, ChIP assays were conducted in HEK293 cells (Fig. 3B). As expected, p65 was rapidly recruited to this promoter following TNF-
stimulation and then disappeared after SNP treatment. In contrast, p50 binding decreased as cells were stimulated with TNF-
and then increased 30 min after SNP treatment. This result suggested exchange of p65/p50 with the repressive p50 homodimer on the NF-
B target gene as a result of SNP treatment.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 3. NO-induced subunit exchange on the mouse and human ICAM-1 gene promoter. A, P19 cells were treated with 0.5 mm SNP for 06 h. ChIP assays were performed with antibodies specific to p65 and p50, and DNA was amplified with primers specific to the mICAM-1 gene promoter and probed. B, HEK293 cells were pretreated with 10 ng/ml TNF- for 02 h prior to treatment with 0.5 mm SNP for 090 min. ChIP assays were performed with antibodies, and DNA was amplified with primers specific to the hICAM-1 gene promoter. Con, control.
|
|
Effects on NF-
B Heterodimerization and Interaction with I
B
To directly examine whether Tyr nitration affected heterodimerization of NF-
B, immunoprecipitations were performed (Fig. 4A). Immune complexes precipitated with anti-p65 or anti-p50 antibodies were probed reciprocally with anti-p50 or anti-p65 antibodies. The results clearly demonstrated decreased heterodimerization after nitration of p65 (lane 3 versus lane 4),despite similar input levels (lanes 1 and 2). To monitor its interaction with I
B
, His-p65 was precipitated with nickel beads and incubated with 35S-labeled I
B
followed by extensive washing. Anti-His antibody showed a similar amount of His-p65 precipitate (Fig. 4B, top panel, lanes 3 and 4). Precipitates from cells exposed to SNP showed significant Tyr nitration of His-p65 (second panel, lane 4). Although I
B
interacted moderately with the unmodified p65 (lower panel, lane 3), it interacted even more strongly with the nitrated p65 (lower panel, lane 4). Taken together, these results confirmed that Tyr nitration of p65 triggered its preferential interaction with I
B
over p50, leading to the formation of suppressive complexes.
SNP-triggered p65 Export to the Cytoplasm with I
B
Since nitrated p65 preferentially interacted with I
B
, we then determined whether cellular localization of p65 was affected by SNP treatment. As expected, p65 was more abundant in the nuclei than in the cytoplasm of P19 control cells, consistent with the constitutive activation of NF-
B in P19 cells (Fig. 5A, top panel, t = 0). SNP dramatically reduced its nuclear level and simultaneously increased its cytoplasmic level (Fig. 5A, top panel). In contrast, no significant changes were observed for p50 (Fig. 5A, middle panel), confirming the lack of SNP effect on p50. As a control, Sp1 was not affected by SNP (Fig. 5A, lower left panel). We also examined TNF-
-stimulated NF-
B (Fig. 5B, lanes 13), and consistently nuclear p65 dramatically decreased after SNP treatment (lanes 47).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 5. Export of nitrated p65 by I B shuttling. A, immunoblot analyses of nuclear and cytoplasmic proteins from P19 cells treated with SNP for 06 h. Blots were probed with antibodies specific to p65, p50, or Sp1. B, HEK293 cells were pretreated with TNF- for 12 h prior to treatment with SNP for 0120 min. Nuclear extracts were immunoblotted with anti-p65 antibody. C, HEK293 cells were pretreated with TNF- for 2 h prior to incubation with 20 nm LMB (2 h) or 10 µm DFO (30 min) before SNP treatment for 2 h. Nuclear extracts were immunoblotted with anti-p65 antibody. DK, fluorescence microscopic analysis of HEK293 cells transfected with pEGFP-c1-p65. The concentrations of SNP, TNF- , LMB, and DFO were 0.5 mm, 10 ng/ml, 20 nm, and 10 µm, respectively. D, untreated cells. E, cells treated with SNP for 2 h. F, cells treated with TNF- for 2 h. G, cells treated with TNF- for 2 h followed by treatment with SNP for 2 h. H, cells treated with TNF- for 2 h followed by treatment with LMB for 2 h. I, same as H followed by treatment with SNP for 2 h. J, cells treated with TNF- for 2 h followed by treatment with DFO for 30 min. K, same as J followed by treatment with SNP for 2 h. L, a statistical summary of the cellular distribution of p65 as determined by fluorescence microscopy. Results were derived from observing at least 200 transfected cells present in multiple microscopic fields from three independent experiments. The percentage of cells exhibiting a nuclear distribution of p65 is indicated for each treatment group. *, p 0.01 versus control (Con); **, p < 0.005 versus TNF- . Cells treated with LMB or DFO did not change their distribution significantly relative to those treated with TNF- alone.
|
|
To determine whether this involved an I
B
-mediated export mechanism, HEK293 cells were stimulated with TNF-
and treated with LMB, an inhibitor of I
B
export, or DFO prior to SNP treatment followed by immunoblotting of the nuclear extracts (Fig. 5C). p65/p50 heterodimers were translocated upon TNF-
stimulation (lane 2). SNP treatment resulted in lower levels of nuclear p65, presumably due to its export (lane 3). LMB and DFO pretreatment prior to SNP blocked the decrease (lanes 4 and 5), indicating that SNP-triggered Tyr nitration of p65 facilitated its export with I
B
.
To better visualize translocation of p65, HEK293 cells were transfected with GFP-fused p65 and treated with various agents (Fig. 5, DK). The statistical analysis of these studies is summarized in Fig. 5L. p65 was initially equally distributed into the cytoplasm and the nuclei (D) but SNP treatment increased cytoplasmic p65 by about 20% (E and L). Most p65 was translocated into the nuclei upon TNF-
stimulation (F) but relocalized into the cytoplasm following SNP treatment (G). Activated p65 was retained in the nuclei by treatment with LMB (H). Furthermore LMB completely blocked the export of p65 induced by SNP (I), supporting the existence of an I
B
-mediated export mechanism for p65 in cells treated with SNP. As predicted, DFO also blocked the export of p65 induced by SNP (J and K). These results confirmed that, in addition to reducing p65/p50 heterodimerization, Tyr nitration of p65 also facilitated its nuclear export together with the inhibitory I
B
.
p65 Nitration at Tyr-66 and Tyr-152
To determine which Tyr residues of p65 were nitrated, cell lysates from P19 cells were subjected to in vitro nitration and immunoprecipitated with anti-p65 antibody followed by immunoblot using anti-NTyr (Fig. 6A, lanes 2 and 3) or anti-p65 to monitor the input (lanes 4 and 5). BSA was used for the control of in vitro nitration (lane 1) (26). Similarly the recombinant p65 (GenBankTM accession no. AAA36408) was subjected to a parallel in vitro nitration and detected with anti-NTyr (Fig. 6B, lanes 2 and 3). As shown, both the endogenous and the recombinant p65 were effectively nitrated. To rule out the possibility of random nitration, purified ligand binding domain of retinoid X receptor, which contains four Tyr residues, was also subjected to in vitro nitration and detected with anti-NTyr (Fig. 6B, lanes 6 and 7) or anti-retinoid X receptor (lanes 8 and 9). This control experiment showed absolutely no nitration on this irrelevant protein and further confirmed that p65 could be nitrated in vitro specifically.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 6. Nitration of the p65 subunit at Tyr-66 and Tyr-152. A, immunoblot analysis of P19 cell extracts nitrated in vitro and immunoprecipitated (IP) with anti-p65 followed by immunoblotting (IB) with anti-NTyr (left panel) or p65 (right panel). BSA was used as a nitration control (lane 1). NO, nitrated samples. Con, untreated controls. B, recombinant p65 was nitrated in vitro. One to ten nanograms of the sample were probed on immunoblots with anti-NTyr antibody (lanes 2 and 3). Lane 4 is unmodified control p65. As a negative nitration control, purified ligand binding domain of retinoid X receptor (RXR) was nitrated in vitro followed by immunoblots with anti-NTyr (lanes 6 and 7) or anti-retinoid X receptor (lanes 8 and 9). C, LC/MS/MS spectrograph of the ionized peptides derived from tryptic digests of p65. The peptide was sequenced as INGYNO2TGPGTVR (residues 6373). Upper spectrum, control peptide (doubly charged at m/z 567.81). Lower spectrum, in vitro nitrated peptide (doubly charged at m/z 590.31). The peaks y8*, y9*, y10*, and a4-NH3* from nitrated samples exhibit a shift of 44.9 Da relative to those of controls. NGY-NO2, nitrated Tyr-66 peptide fragment. #, immonium ion of nitrotyrosine. D, LC/MS/MS spectrograph of the ionized peptides derived from tryptic digests of p65. The peptide was sequenced as GDYNO2DLNAVR (residues 150158). Upper spectrum, control peptide (doubly charged at m/z 511.81). Lower spectrum, in vitro nitrated peptide (doubly charged at m/z 534.32). The peaks y7*, b3*, and b4* from nitrated samples exhibit a shift of 44.9 Da relative to those of controls. #, immonium ion of nitrotyrosine.
|
|
The specifically nitrated Tyr residues were then identified with mass spectrometry. The nitrated recombinant p65 (Fig. 6B, lanes 2 and 3) and the control p65 protein (lane 4) were subjected to trypsin digestion followed by LC/MS/MS. The 44.9-Da difference in precursor molecular mass between the two ions was consistent with the addition of a nitro group and loss of a hydrogen atom (14). As shown in Fig. 6C, amino acid mapping of this peptide by MS/MS analysis clearly demonstrated a 44.9-Da increase (lower panel) from the un-nitrated peptide (upper panel), consistent with nitration of the peptide. Singly charged y7 ions from both nitrated and control peptides had a mass of 687.41 Da, but the masses of singly charged y8, y9, and y10 ions all showed an increase of 44.9 Da in the nitrated peptide. In addition, the 181.07-Da peak confirmed the presence of the immonium ion of NTyr, whereas the 136.10-Da Tyr immonium ion was detected from the un-nitrated precursor. Also the shift from 335.14 to 380.14 Da indicated the conversion of the internal fragment NGY (residues 6466) to NGY-NO2, confirming nitration at Tyr-66 of a peptide corresponding to residues 6373 with sequence INGYTGPGTVR (Fig. 6C, upper and lower panels).
Similarly Fig. 6D shows amino acid mapping of the peptide corresponding to amino acids 150158 with sequence GDYDLNAVR. Peak y6 from both the nitrated and control peptides had a mass of 687.41 Da, but the mass of y7 increased 44.9 Da in the nitrated peptide (upper and lower panels). Peak b2 from both nitrated and control peptides had a mass of 173.06 Da, but the masses of peaks b3 and b4 also showed an increase of 44.9 Da in the nitrated peptide. The NTyr immonium fragment was detected at 181.07 Da, which confirmed nitration of Tyr-152. This mass spectrometry analysis clearly confirmed that two tyrosine residues (Tyr-66 and Tyr-152), among a total of 11 tyrosine residues, were specifically and strongly nitrated. Both Tyr-66 and Tyr-152 are located in the Rel homology domain (RHD), spanning residues 19306, which suggests a potential biological significance.
Nitration at both Tyr-66 and Tyr-152 Is Important for p65 Export and Activity
Mass spectrometry revealed two nitrated Tyr residues in RHD of p65 (Fig. 7A). To determine whether these residues were important for p65 property or activity, we constructed point mutations at Tyr-66 or Tyr-152 on a GFP-fused p65. HEK293 cells were transfected with wild type or mutant p65 and treated with TNF-
and peroxynitrite (Fig. 7B). Consistent with the result of SNP treatment (Fig. 5L), peroxynitrite also induced export of the wild type p65 (Fig. 7B, wt column). Nuclear retention of these two point mutants, Y66F and Y152F, was slightly less efficient than the wild type. Interestingly peroxynitrite could no longer induce their export effectively. To further examine the effects of mutation on p65 biological activity, a reporter assay was conducted. In this assay, both mutants also exhibited a lower transcriptional activity than the wild type (Fig. 7C) consistent with the less efficient nuclear retention observed for these mutated p65 proteins (Fig. 7B). The wild type p65 was significantly affected by peroxynitrite treatment (45%), whereas both mutants were only moderately affected (about 30%), presumably due to the presence of one of the two Tyr residues. These results confirmed that nitration at both Tyr-66 and Tyr-152 was important for nuclear export and its transcriptional activity.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 7. Effects of Y66F and Y152F mutations. A, a schematic representation of p65 (amino acids 1551), including RHD, nuclear localization signal (NLS) and transactivating domain (TAD). RHD spans amino acids 19306. Tyr-66 and Tyr-152 were each mutated to phenylalanine. B, HEK293 cells were transfected with wild type GFP-fused p65 (wt) or mutants (Y66F and Y152F) and were treated with TNF- for 4 h prior to treatment with 0.1 mm peroxynitrite for 2 h. Results are derived from observing at least 100 transfected cells present in multiple microscopic fields from two independent experiments. The percentage of cells exhibiting nuclear distribution of p65 is indicated for each group. *, p < 0.01 versus TNF- . C, P19 cells were transfected with wild type or mutant GFP-p65 construct and were treated with peroxynitrite for 2 h. Reporter assays were conducted two times. *, p < 0.01; **, p < 0.05. Con, control; CMV, cytomegalovirus vector; RLU, relative luciferase unit.
|
|
 |
DISCUSSION
|
---|
NF-
B has attracted an enormous amount of attention because of its role in a wide variety of cellular processes, particularly the immune and stress responses, and in diseases. The activating and inhibitory mechanisms of NF-
B have been widely investigated to determine potential targets for drug intervention. Several post-translational modifications on components involved in NF-
B activity are known. Our study presents an additional, perhaps more general, inhibitory signal to rapidly inactivate NF-
B by Tyr nitration on the p65 subunit. While multiple NO-triggered events are involved in the regulation of NF-
B, the mechanism mediated by Tyr nitration on p65 can certainly provide a very rapid off-switch for readily active NF-
B upon peroxynitrite formation. Nevertheless our results could not rule out suppression by S-nitrosylation, such as that which occurred on p50, in HEK293 cells. Interestingly for all genes tested, we demonstrated that the peroxynitrite/Tyr nitration pathway could be the primary inactivating mechanism (c-myc, ICAM-1, cyclin D1, cIAP-1, and IL-8) in both constitutively active (P19 and SH-SY5Y) and TNF-
-stimulated NF-
B (HEK293 and COS-1) systems.
Tyr nitration of p65 clearly triggered at least two important events: 1) replacement of p65/p50 with the repressive p50/p50 complex and 2) subsequent association of p65 with I
B
for export. I
B
is known to act as a shuttle between the nuclei and cytoplasm through a nuclear export signal (27, 28). Through its preferential interaction with I
B
, the nitrated p65 could be loaded on I
B
and subsequently exported from the nuclei. These two events could independently or synergistically inactivate p65 transcriptional activity.
These two events were further supported by the identification of specific Tyr nitration of p65 (Tyr-66 and Tyr-152). NF-
B translocation into nuclei is essential for its activation. On the contrary, S-nitrosylation at Cys-62 of the p50 subunit has been considered to be a major target of NO-triggered inhibition of NF-
B activity (1820). NO can also stabilize I
B
in the cytoplasm by nitrosylating I
B kinase ß at Cys-179 (21, 22, 29). Our study demonstrated an additional mechanism that directly and rapidly targeted the p65 subunit whose protein interaction and nuclear translocation property was altered by Tyr nitration. As a result, active NF-
B was rapidly inactivated. The nitration occurred at two specific Tyr residues of p65, Tyr-66 and Tyr-152, within its RHD (Fig. 6), which is known to be involved in interaction with other Rel family proteins and DNA binding (30). Tyr-66 is conserved in RHD-containing NF-
B family members, including p65, p50, p52, p100, p105, and c-Rel, but Tyr-152 is unique to p65. The anti-NTyr antibody detected a weak band of p50 (Fig. 2), which could be due to nitration on the conserved Tyr-66 residue. In addition, nitration might cause a conformational change of RHD that disrupts interaction with p50 but enhances interaction with I
B
. However, this remains to be tested experimentally. NF-
B is known to activate inducible NO synthase to produce NO in response to stressful stimuli (31). Colasanti et al. (32) observed that exogenous NO suppressed inducible NO synthase mRNA expression and prevented TNF-
-stimulated NF-
B target gene expression. It was suggested that NO decreased NF-
B availability on the inducible NO synthase gene promoter. Our study provided an explanation for the feedback inhibition mechanism of NO by inactivating NF-
B through Tyr nitration of p65.
In most normal conditions, NF-
B exists in its inactive form by association with I
B
and is activated by a wide range of stimuli. Constitutively active NF-
B is widely known to be associated with various hematological malignancies and solid tumors including breast cancer, pancreatic carcinoma, and prostate cancer (1, 3, 3338). In these cases, NF-
B induces cell survival, cell proliferation, angiogenesis, and metastasis of these cancers by promoting the expression of survival factors such as members of the cellular inhibitor of apoptosis family (cIAP-1, cIAP-2, and X-linked inhibitor of apoptosis protein), the Bcl-2 homologues (Bcl-2, Bfl-1/A1, and Bcl-XL), cyclin D1, and c-Myc (23, 39, 40). Our results suggest that the ability of NO-generating agents to rapidly and effectively inactivate NF-
B provides a potential route of drug intervention for various diseases, particularly cancers.
 |
ACKNOWLEDGMENTS
|
---|
We thank Drs. Bruce Witthuhn, LeeAnn Higgins, and Kathryn Fuller for mass spectrometry analysis in the Mass Spectrometry Consortium for the Life Sciences (University of Minnesota Department of Biochemistry, Molecular Biology and Biophysics).
 |
FOOTNOTES
|
---|
Received, December 6, 2004, and in revised form, January 15, 2005.
1 The abbreviations used are: NF-
B, nuclear factor-
B; NTyr, nitrotyrosine; SNP, sodium nitroprusside; DFO, deferoxamine; ODQ, 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one; ChIP, chromatin immunoprecipitation; RHD, Rel homology domain; TNF, tumor necrosis factor; CBP, cAMP-response element-binding protein (CREB)-binding protein; EGFP, enhanced green fluorescent protein; HEK, human embryonic kidney; ICAM-1, intracellular adhesion molecule-1 (h, human; m, mouse); cIAP, cellular inhibitor of apoptosis protein; IL-8, interleukin-8; Ni-NTA, nickel-nitrilotriacetic acid; MLB, leptomycin B; GFP, green fluorescent protein. 
* This work was supported by National Institutes of Health Grants DK54733, DK60521, K02 DA13926, DA11190, and DA11806 (to L.-N W.). 
Published, MCP Papers in Press, January 18, 2005, DOI 10.1074/mcp.M400195-MCP200
To whom correspondence should be addressed: Dept. of Pharmacology, University of Minnesota, 6-120 Jackson Hall, 321 Church St. S E., Minneapolis, MN 55455. Tel.: 612-625-9402; Fax: 612-625-8408; E-mail: weixx009{at}umn.edu
 |
REFERENCES
|
---|
- Baldwin, A. S.
(2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-
B.
J. Clin. Investig.
107, 241
246[Free Full Text]
- Dixit, V., and Mak, T. W.
(2002) NF-
B signaling: many roads lead to Madrid.
Cell
111, 615
619[Medline]
- Karin, M., Cao, Y., Greten, F. R., and Li, Z. W.
(2002) NF-
B in cancer: from innocent bystander to major culprit.
Nat. Rev. Cancer
2, 301
310[CrossRef][Medline]
- Li, Q., and Verma, I. M.
(2002) NF-
B regulation in the immune system.
Nat. Rev. Immunol.
2, 725
734[CrossRef][Medline]
- Baek, S. H., Ohgi, K. A., Rose, D. W., Koo, E. H., Glass, C. K., and Rosenfeld, M. G.
(2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-
B and ß-amyloid precursor protein.
Cell
110, 55
67[Medline]
- Nakamura, Y., Grumont, R.J., and Gerondakis, S.
(2002) NF-
B1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.
Mol. Cell. Biol.
22, 5563
5574[Abstract/Free Full Text]
- Zhong, H., May, M. J., Jimi, E., and Ghosh, S.
(2002) The phosphorylation status of nuclear NF-
B determines its association with CBP/p300 or HDAC-1.
Mol. Cell
9, 625
636[CrossRef][Medline]
- Rocha, S., Martin, A. M., Meek, D. W., and Perkins, N. D.
(2003a) p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-
B subunit with histone deacetylase 1.
Mol. Cell. Biol.
23, 4713
4727[Abstract/Free Full Text]
- Ghosh, S., and Karin, M.
(2002) Missing pieces in the NF-
B puzzle.
Cell
109, S81
S96[CrossRef][Medline]
- Chen, L. F., Fischle, W., Verdinm, E., and Greene, W. C.
(2001) Duration of nuclear NF-
B action regulated by reversible acetylation.
Science
293, 1653
1657[Abstract/Free Full Text]
- Chen, L. F., Mu, Y., and Greene, W. C.
(2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-
B.
EMBO J.
21, 6539
6548[Abstract/Free Full Text]
- Jang, M. K., Goo, Y. H., Sohn, Y. C., Kim, Y. S., Lee, S. K., Kang, H., Cheong, J., and Lee, J. W.
(2001) Ca2+/calmodulin-dependent protein kinase IV stimulates nuclear factor-
B transactivation via phosphorylation of the p65 subunit.
J. Biol. Chem.
276, 20005
20010[Abstract/Free Full Text]
- Madrid, L. V. Mayo, M. W., Reuther, J. Y., and Baldwin, A. S., Jr.
(2001) Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-
B through utilization of the I
B kinase and activation of the mitogen-activated protein kinase p38.
J. Biol. Chem.
276, 18934
18940[Abstract/Free Full Text]
- Zhong, H., Voll, R. E., and Ghosh, S.
(1998) Phosphorylation of NF-
B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300.
Mol. Cell
1, 661
671[CrossRef][Medline]
- Wang, D., Westerheide, S. D., Hanson, J. L., and Baldwin, A. S., Jr.
(2000) Tumor necrosis factor
-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II.
J. Biol. Chem.
275, 32592
32597[Abstract/Free Full Text]
- Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., and Chaudhuri, G.
(1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Proc. Natl. Acad. Sci. U S A.
84, 9265
9269[Abstract]
- Bogdan, C.
(2001) Nitric oxide and the regulation of gene expression.
Trends Cell Biol.
11, 66
75[CrossRef][Medline]
- Marshall, H. E., and Stamler, J. S.
(2001) Inhibition of NF-
B by S-nitrosylation.
Biochemistry
40, 1688
1693[CrossRef][Medline]
- DelaTorre, A., Schroeder, R. A., Punzalan, C., and Kuo, P. C.
(1999) Endotoxin-mediated S-nitrosylation of p50 alters NF-
B-dependent gene transcription in ANA-1 murine macrophages.
J. Immunol.
162, 4101
4108[Abstract/Free Full Text]
- Matthews, J. R., Botting, C. H., Panico, M., Morris, H. R., and Hay, R. T.
(1996) Inhibition of NF-
B DNA binding by nitric oxide.
Nucleic Acids Res.
24, 2236
2242[Abstract/Free Full Text]
- Kapahi, P., Takahashi, T., Natoli, G., Adams, S. R., Chen, Y., Tsien, R. Y., and Karin, M.
(2000) Inhibition of NF-
B activation by arsenite through reaction with a critical cysteine in the activation loop of I
B kinase.
J. Biol. Chem.
275, 36062
36066[Abstract/Free Full Text]
- Reynaert, N. L., Ckless, K., Korn, S. H., Vos, N., Guala, A. S., Wouters, E. F., van der Vliet, A., and Janssen-Heininger, Y. M.
(2004) Nitric oxide represses inhibitory
B kinase through S-nitrosylation.
Proc. Natl. Acad. Sci. U S A.
101, 8945
8950[Abstract/Free Full Text]
- Park, S. W., and Wei, L. N.
(2003) Regulation of c-myc gene by nitric oxide via inactivating NF-
B complex in P19 mouse embryonal carcinoma cells.
J. Biol. Chem.
278, 29776
29782[Abstract/Free Full Text]
- Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K., and Siebenlist, U.
(1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-
B-mediated inhibition.
Nature
359, 339
342[CrossRef][Medline]
- Park, S. W., Li, J., Loh, H. H., and Wei, L. N.
(2002) A novel signaling pathway of nitric oxide on transcriptional regulation of mouse
opioid receptor gene.
J. Neurosci.
22, 7941
7947[Abstract/Free Full Text]
- Haqqani, A. S., Kelly, J. F., and Birnboim, H. C.
(2002) Selective nitration of histone tyrosine residues in vivo in mutatect tumors.
J. Biol. Chem.
277, 3614
3621[Abstract/Free Full Text]
- Birbach, A., Gold, P., Binder, B. R., Hofer, E., de Martin, R., and Schmid, J. A.
(2002) Signaling molecules of the NF-
B pathway shuttle constitutively between cytoplasm and nucleus.
J. Biol. Chem.
277, 10842
10851[Abstract/Free Full Text]
- Spiecker, M., Peng, H. B., and Liao, J. K.
(1997) Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of I
B
.
J. Biol. Chem.
272, 30969
30974[Abstract/Free Full Text]
- Chang, K., Lee, S. J., Cheong, I., Billiar, T. R., Chung, H. T., Han, J. A., Kwon, Y. G., Ha, K. S., and Kim. Y. M.
(2004) Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of I
B.
Exp. Mol. Med.
36, 311
324[Medline]
- Huguet, C., Crepieux, P., and Laudet, V.
(1997) Rel/NF-
B transcription factors and I
B inhibitors: evolution from a unique common ancestor.
Oncogene
15, 2965
2974[CrossRef][Medline]
- Xie, Q. W., Kashiwabara, Y., and Nathan, C.
(1994) Role of transcription factor NF-
B/Rel in induction of nitric oxide synthase.
J. Biol. Chem.
269, 4705
4708[Abstract/Free Full Text]
- Colasanti, M., Persichini, T., Menegazzi, M., Mariotto, S., Giordano, E., Caldarera, C. M., Sogos, V., Lauro, G. M., and Suzuki, H.
(1995) Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide.
J. Biol. Chem.
270, 26731
26733[Abstract/Free Full Text]
- Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K., and Baldwin, A. S., Jr.
(2000) Selective activation of NF-
B subunits in human breast cancer: potential roles for NF-
B2/p52 and for Bcl-3.
Oncogene
19, 1123
1131[CrossRef][Medline]
- Karin, M., and Lin, A.
(2002) NF-
B at the crossroads of life and death.
Nat. Immunol.
3, 221
227[CrossRef][Medline]
- Kim, D. W., Sovak, M. A., Zanieski, G., Nonet, G., Romieu-Mourez, R., Lau, A. W., Hafer, L. J., Yaswen, P., Stampfer, M., Rogers, A. E., Russo, J., and Sonenshein, G. E.
(2000) Activation of NF-
B/Rel occurs early during neoplastic transformation of mammary cells.
Carcinogenesis
21, 871
879[Abstract/Free Full Text]
- Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., Jr., and Sledge, G. W., Jr.
(1997) Constitutive activation of NF-
B during progression of breast cancer to hormone-independent growth.
Mol. Cell. Biol.
17, 3629
3639[Abstract]
- Suh, J., and Rabson, A. B.
(2004) NF-
B activation in human prostate cancer: important mediator or epiphenomenon?
J. Cell. Biochem.
91, 100
117[CrossRef][Medline]
- Zerbini, L. F., Wang, Y., Cho, J. Y., and Libermann, T. A.
(2003) Constitutive activation of nuclear factor
B p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Cancer Res.
63, 2206
2215[Abstract/Free Full Text]
- Kucharczak, J., Simmons, M. J., Fan, Y., and Gelinas, C.
(2003) To be, or not to be: NF-
B is the answerrole of Rel/NF-
B in the regulation of apoptosis.
Oncogene
22, 8961
8982[CrossRef][Medline]
- Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr.
(1998) NF-
B antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.
Science
281, 1680
1683[Abstract/Free Full Text]